Author Correction: Targeting public neoantigens for cancer immunotherapy

Alexander H Pearlman^{1

2

3}, Michael S Hwang^{1

2

3

4}, Maximilian F Konig^{1

2

3

5}, Emily Han-Chung Hsiue^{1

2

3}, Jacqueline Douglass^{1

2

3}, Sarah R DiNapoli^{1

2

3}, Brian J Mog^{1

2

3

6}, Chetan Bettegowda^{1

2

7

8}, Drew M Pardoll^{8

9}, Sandra B Gabelli^{8

10

11}, Nicholas Papadopoulos^{1

2

9

12

13}, Kenneth W Kinzler^{1

2

8

9

13}, Bert Vogelstein^{1

2

3

8

9

12

13}, Shibin Zhou^{14

15

16

17}

Affiliations

¹ Ludwig Center, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
² Lustgarten Pancreatic Cancer Research Laboratory, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
³ Howard Hughes Medical Institute, Chevy Chase, MD, USA.
⁴ Genentech, Inc., South San Francisco, CA, USA.
⁵ Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
⁶ Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.
⁷ Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
⁸ Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
⁹ Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
¹⁰ Department of Biophysics and Biophysical Chemistry, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
¹¹ Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
¹² Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
¹³ Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
¹⁴ Ludwig Center, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. sbzhou@jhmi.edu.
¹⁵ Lustgarten Pancreatic Cancer Research Laboratory, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. sbzhou@jhmi.edu.
¹⁶ Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. sbzhou@jhmi.edu.
¹⁷ Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. sbzhou@jhmi.edu.

PMID: 35122030
PMCID: PMC11003703
DOI: 10.1038/s43018-021-00246-0

Published Erratum

Author Correction: Targeting public neoantigens for cancer immunotherapy

Alexander H Pearlman et al. Nat Cancer. 2021 Aug.

. 2021 Aug;2(8):865-867.

doi: 10.1038/s43018-021-00246-0.

Authors

Affiliations

¹ Ludwig Center, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
² Lustgarten Pancreatic Cancer Research Laboratory, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
³ Howard Hughes Medical Institute, Chevy Chase, MD, USA.
⁴ Genentech, Inc., South San Francisco, CA, USA.
⁵ Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
⁶ Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.
⁷ Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
⁸ Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
⁹ Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
¹⁰ Department of Biophysics and Biophysical Chemistry, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
¹¹ Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
¹² Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
¹³ Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
¹⁴ Ludwig Center, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. sbzhou@jhmi.edu.
¹⁵ Lustgarten Pancreatic Cancer Research Laboratory, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. sbzhou@jhmi.edu.
¹⁶ Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. sbzhou@jhmi.edu.
¹⁷ Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. sbzhou@jhmi.edu.

PMID: 35122030
PMCID: PMC11003703
DOI: 10.1038/s43018-021-00246-0

No abstract available

PubMed Disclaimer

Figures

See this image and copyright information in PMC

Erratum for

Targeting public neoantigens for cancer immunotherapy.
Pearlman AH, Hwang MS, Konig MF, Hsiue EH, Douglass J, DiNapoli SR, Mog BJ, Bettegowda C, Pardoll DM, Gabelli SB, Papadopoulos N, Kinzler KW, Vogelstein B, Zhou S. Pearlman AH, et al. Nat Cancer. 2021 May;2(5):487-497. doi: 10.1038/s43018-021-00210-y. Epub 2021 May 17. Nat Cancer. 2021. PMID: 34676374 Free PMC article. Review.

Publication types

Actions

Grants and funding

T32 GM136577/GM/NIGMS NIH HHS/United States

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Targeting public neoantigens for cancer immunotherapy

Affiliations

Author Correction: Targeting public neoantigens for cancer immunotherapy

Authors

Affiliations

Figures

Erratum for

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources